Novel adenovirus-based helper system to support production of recombinant parvovirus (Q39814060)

14 September 2017

Novel adenovirus-based helper system to support production of recombinant parvovirus (English)

1 reference

14 September 2017

1 reference

N El-Andaloussi

1

1 reference

14 September 2017

M Endele

2

1 reference

14 September 2017

B Leuchs

3

1 reference

14 September 2017

S Bonifati

4

1 reference

14 September 2017

J Kleinschmidt

5

1 reference

14 September 2017

J Rommelaere

6

1 reference

14 September 2017

A Marchini

7

1 reference

14 September 2017

19 November 2010

1 reference

14 September 2017

1 reference

14 September 2017

18

1 reference

14 September 2017

4

1 reference

14 September 2017

240-249

1 reference

https://scigraph.springernature.com/pub.10.1038/cgt.2010.73

14 September 2017

0 references

cites work

Antineoplasic activity of parvoviruses

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.73

ADENOVIRUS-ASSOCIATED DEFECTIVE VIRUS PARTICLES

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.73

cis requirements for the efficient production of recombinant DNA vectors based on autonomous parvoviruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.73

Vectors based on autonomous parvoviruses: novel tools to treat cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.73

Potentiation of a recombinant oncolytic parvovirus by expression of Apoptin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.73

In vivo anti-tumour activity of recombinant MVM parvoviral vectors carrying the human interleukin-2 cDNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.73

Highly efficient transduction and expression of cytokine genes in human tumor cells by means of autonomous parvovirus vectors; generation of antitumor responses in recipient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.73

Transduction of human MCP-3 by a parvoviral vector induces leukocyte infiltration and reduces growth of human cervical carcinoma cell xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.73

Suppression of metastatic hemangiosarcoma by a parvovirus MVMp vector transducing the IP-10 chemokine into immunocompetent mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.73

Adenovirus containing a deletion of the early region 2A gene allows growth of adeno-associated virus with decreased efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.73

Efficient synthesis of adeno-associated virus structural proteins requires both adenovirus DNA binding protein and VA I RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.73

Adeno-associated viruses can induce phosphorylation of eIF2alpha via PKR activation, which can be overcome by helper adenovirus type 5 virus-associated RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.73

Progress in adeno-associated virus type 2 vector production: promises and prospects for clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.73

Adeno-associated virus vectors can be efficiently produced without helper virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.73

Novel tools for production and purification of recombinant adenoassociated virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.73

The genome of human parvovirus b19 can replicate in nonpermissive cells with the help of adenovirus genes and produces infectious virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.73

Replication of minute virus of mice DNA in adenovirus-infected or adenovirus-transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.73

Chimeric and pseudotyped parvoviruses minimize the contamination of recombinant stocks with replication-competent viruses and identify a DNA sequence that restricts parvovirus H-1 in mouse cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.73

A novel adenovirus vector for easy cloning in the E3 region downstream of the CMV promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.73

A simplified system for generating recombinant adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.73

Transfection of mammalian cells using linear polyethylenimine is a simple and effective means of producing recombinant adeno-associated virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.73

Autonomous parvoviruses as gene transfer vehicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.73

MCP-3 (CCL7) delivered by parvovirus MVMp reduces tumorigenicity of mouse melanoma cells through activation of T lymphocytes and NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.73

inferred from DOI database lookup

7 January 2021

based on heuristic

TNF-α and the IFN-γ-inducible protein 10 (IP-10/CXCL-10) delivered by parvoviral vectors act in synergy to induce antitumor effects in mouse glioblastoma

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.73

inferred from DOI database lookup

7 January 2021

based on heuristic

Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.73

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/CGT.2010.73

1 reference

Dimensions Publication ID

14 September 2017

0 references

1 reference